Skip to Main Content

Paper Details

Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC).
Crit Rev Oncol Hematol
14
2020
Author NameAffiliation
Firas H WehbeNorthwestern University
Massimo CristofanilliRobert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University
  • 1 - 2

Datasets

Release 1.2